Interaction between our two genomes, nuclear and mitochondrial, is the key to healthy aging

The study, led by Dr. José Antonio Enriquez, sheds light on the physiological differences between individuals and opens the way to the study of common aging-related conditions, such as diabetes, cardiovascular diseases, and cancer. The Nature study also provides extremely valuable information about how to best use mitochondrial donation technology. This therapeutic approach, popularly known for producing "three-parent babies," is designed to avoid the transmission of inherited pathogenic mutations and has already been approved in the UK.

Of the more than 20000 human genes, 37 are found not in the cell nucleus but in the mitochondria, small organelles that function as energy factories. The small mitochondrial genome, which we inherit from our mothers, is known as the mitochondrial DNA. Like its nuclear equivalent, the mitochondrial genome shows a degree of genetic variability, both in mice and humans.

The CNIC-led team found that non-pathogenic mitochondrial DNA variants have different impacts on organismal metabolism and aging. Dr. Enriquez explains that the study uncovers how "variation in just a few genes can determine whether we experience healthy aging." The results represent a major advance in our understanding of the aging process, showing that "non-pathogenic differences in mitochondrial function have direct repercussions on the pace of aging."

"The key to this study was understanding how the combination and interaction of our two genomes, the nuclear and the mitochondrial, triggers a cellular adaptation with repercussions throughout our lives," explains study first author Dr. Ana Latorre-Pellicer.

By using animal models, the research team obtained robust evidence that the simple measure of changing an animal's mitochondrial DNA triggers a series of adaptive cellular mechanisms in young animals that ensure a more healthy aging process. "If we can understand the biology underlying healthy aging that is free of age-associated diseases, we will be in a position to maintain long-lasting health during the aging process," affirms Dr. Latorre-Pellicer.

Three-parent babies

Mitochondrial donation technology has the potential to prevent the transmission of disease-causing mitochondrial DNA. This therapeutic approach, aimed at avoiding transmission of heritable pathological mutations, consists of replacing the suboptimal maternal mitochondria with mitochondria from a healthy donor. However, the use of this technology, popular known for producing "three-parent babies," and which is already approved in the UK, requires a thorough understanding of the physiological impact of mitochondrial DNA variability.

The results of the study underline the importance of making sure that the donor mitochondrial DNA in mitochondrial donation procedures is an appropriate match for the recipient's nuclear genome. The CNIC researchers are keen to stress that the potential risks of this procedure should not be ignored. "Just as with organ transplantation and blood transfusion, it is important to select mitochondrial donors, to ensure that the new mitochondrial DNA is genetically similar to that of the mother whose eggs require mitochondrial DNA replacement," concludes Dr. Enriquez.